Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461355 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Post-Stroke Aphasia
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02461355 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 2 participants.
The verdict
NCT02461355, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.
Interventions
- DEVICE Sham tDCS
- DEVICE Anodal tDCS
- BEHAVIORAL Aphasia therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461355
The ClinicalTrials.gov registry entry for NCT02461355 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham tDCS is the first listed.
NCT02461355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02461355 about?
NCT02461355 is a clinical study titled "Transcranial Direct Current Stimulation for Post-Stroke Aphasia". This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.
What is the current status of trial NCT02461355?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2015-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02461355?
The interventions under investigation include: Sham tDCS (DEVICE), Anodal tDCS (DEVICE), Aphasia therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02461355?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.